BACKGROUND: During the past 2 decades, invasive trichosporonosis has emerged as an opportunistic infectious disease in immunocompromised patients. However, no case series have been reported recently. METHODS: All patients with a culture that was positive for Trichosporon species from May 2000 through May 2008 at a medical center were evaluated. The identity of all Trichosporon species was confirmed by analysis of the intergenic spacer 1 region of the fungal ribosomal RNA gene. In vitro susceptibility testing was performed using the reference broth microdilution method. RESULTS: Forty-three patients were found to have a culture that was positive for Trichosporon species. T. asahii was the most frequently isolated species (32 isolates; 74%), followed by T. dermatis (5; 12%), T. montevideense (2; 5%), and T. asteroides (1; 2%), T. cutaneum (1; 2%), T. faecale (1; 2%), and T. ovoides (1; 2%). Nineteen patients had invasive infections; 16 (84%) were caused by T. asahii, and 1 (5%) each was caused by T. dermatis, T. montevideense, and T. asteroides. Of the 19 episodes of invasive trichosporonosis, 14 (74%) were fungemia, 3 (16%) were pulmonary infection, and 1 (5%) each was soft-tissue infection and meningitis. Most invasive infections were associated with prior antibiotic therapy (95%), use of a central catheter (90%), malignancy (58%), and intensive care unit admission (47%). Azoles had good in vitro activity, whereas amphotericin B and echinocandins were not active against Trichosporon isolates. The 30-day all-cause mortality rate was 42% and was higher among patients with a malignancy (55%) than among those without an underlying malignancy (25%). CONCLUSIONS: Invasive trichosporonosis tended to develop in patients with an underlying malignancy and to be associated with higher mortality. T. asahii and other unusual Trichosporon species may cause invasive trichosporonosis.
BACKGROUND: During the past 2 decades, invasive trichosporonosis has emerged as an opportunistic infectious disease in immunocompromised patients. However, no case series have been reported recently. METHODS: All patients with a culture that was positive for Trichosporon species from May 2000 through May 2008 at a medical center were evaluated. The identity of all Trichosporon species was confirmed by analysis of the intergenic spacer 1 region of the fungal ribosomal RNA gene. In vitro susceptibility testing was performed using the reference broth microdilution method. RESULTS: Forty-three patients were found to have a culture that was positive for Trichosporon species. T. asahii was the most frequently isolated species (32 isolates; 74%), followed by T. dermatis (5; 12%), T. montevideense (2; 5%), and T. asteroides (1; 2%), T. cutaneum (1; 2%), T. faecale (1; 2%), and T. ovoides (1; 2%). Nineteen patients had invasive infections; 16 (84%) were caused by T. asahii, and 1 (5%) each was caused by T. dermatis, T. montevideense, and T. asteroides. Of the 19 episodes of invasive trichosporonosis, 14 (74%) were fungemia, 3 (16%) were pulmonary infection, and 1 (5%) each was soft-tissue infection and meningitis. Most invasive infections were associated with prior antibiotic therapy (95%), use of a central catheter (90%), malignancy (58%), and intensive care unit admission (47%). Azoles had good in vitro activity, whereas amphotericin B and echinocandins were not active against Trichosporon isolates. The 30-day all-cause mortality rate was 42% and was higher among patients with a malignancy (55%) than among those without an underlying malignancy (25%). CONCLUSIONS: Invasive trichosporonosis tended to develop in patients with an underlying malignancy and to be associated with higher mortality. T. asahii and other unusual Trichosporon species may cause invasive trichosporonosis.
Authors: Moan Shane Tsai; Yun Liang Yang; An Huei Wang; Lih Shinn Wang; Daniel C T Lu; Ci Hong Liou; Li Yun Hsieh; Chi Jung Wu; Ming Fang Cheng; Zhi Yuan Shi; Hsiu Jung Lo Journal: Mycopathologia Date: 2012-02-09 Impact factor: 2.574
Authors: Li-Na Guo; Shu-Ying Yu; Po-Ren Hsueh; Abdullah M S Al-Hatmi; Jacques F Meis; Ferry Hagen; Meng Xiao; He Wang; Cinzia Barresi; Meng-Lan Zhou; G Sybren de Hoog; Ying-Chun Xu Journal: J Clin Microbiol Date: 2019-01-30 Impact factor: 5.948
Authors: Elaine Cristina Francisco; João N de Almeida Junior; Flávio Queiroz-Telles; Valério Rodrigues Aquino; Ana Verena A Mendes; Marcio de Oliveira Silva; Paulo de Tarso O E Castro; Thais Guimarães; Vinicius Ponzio; Rosane C Hahn; Guilherme M Chaves; Arnaldo L Colombo Journal: Antimicrob Agents Chemother Date: 2021-02-17 Impact factor: 5.191
Authors: M Treviño; C García-Riestra; P Areses; X García; D Navarro; F J Suárez; I A López-Dequidt; O Zaragoza; M Cuenca-Estrella Journal: Eur J Clin Microbiol Infect Dis Date: 2014-04-10 Impact factor: 3.267
Authors: Ratna Mohd Tap; Parameswari Sabaratnam; Nur Yasmin Ramli; Rohaidah Hashim; Abd Razak Mohd Fuat; Pey Peng Ng; Husna Khairam; Norazah Ahmad Journal: Mycopathologia Date: 2015-10-22 Impact factor: 2.574